We are live on ! Find out more
HUMA icon

Humacyte
HUMA

61 hedge funds and large institutions have $69M invested in Humacyte in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 9

178% more call options, than puts

Call options by funds: $2.68M | Put options by funds: $964K

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

91% more funds holding

Funds holding: 32 → 61 (+29)

2.26% more ownership

Funds ownership: 6.99% → 9.25% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $77.5M → $69M (-$8.53M)

Holders
61
Holders Change
+29
Holders Change %
+90.63%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
39
Increased
10
Reduced
5
Closed
9
Calls
$2.68M
Puts
$964K
Net Calls
+$1.71M
Net Calls Change
-$779K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.9M
2
UOC
UBS O'Connor
Illinois
+$8.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$8.69M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.67M
5
Charles Schwab
Charles Schwab
California
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$17.4M
2
DCP
Diameter Capital Partners
New York
-$6.47M
3
CH
CVI Holdings
Delaware
-$5.8M
4
MIM
Monashee Investment Management
Massachusetts
-$3.46M
5
MS
Maven Securities
Jersey
-$2.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$146K +$18.3K +1,850 +10%
VF
27
Virtu Financial
New York
$144K +$196K +19,851 New
Citadel Advisors
28
Citadel Advisors
Florida
$144K +$197K +19,893 New
EAM
29
Exos Asset Management
New York
$117K -$27.7K -2,803 -15%
Simplex Trading
30
Simplex Trading
Illinois
$110K +$150K +15,203 New
Renaissance Technologies
31
Renaissance Technologies
New York
$107K +$146K +14,800 New
JP Morgan Chase
32
JP Morgan Chase
New York
$105K +$142K +14,398 New
ProShare Advisors
33
ProShare Advisors
Maryland
$105K +$143K +14,506 New
ASRS
34
Arizona State Retirement System
Arizona
$100K +$137K +13,862 New
Legal & General Group
35
Legal & General Group
United Kingdom
$99K +$135K +13,606 New
UBS AM
36
UBS AM
Illinois
$98.6K +$135K +13,600 New
Janus Henderson Group
37
Janus Henderson Group
United Kingdom
$98K +$134K +13,513 New
Zurich Cantonal Bank
38
Zurich Cantonal Bank
Switzerland
$96K +$131K +13,230 New
Brown Advisory
39
Brown Advisory
Maryland
$95K – – –
WAM
40
Wolverine Asset Management
Illinois
$95K +$130K +13,150 New
VFIC
41
Valley Forge Investment Consultants
Pennsylvania
$80K – – –
UAS
42
United Asset Strategies
New York
$75K +$20 +2 +0%
Jane Street
43
Jane Street
New York
$74K +$99.8K +10,086 New
PTC
44
Philadelphia Trust Company
Pennsylvania
$73K -$49.5K -5,000 -33%
Teacher Retirement System of Texas
45
Teacher Retirement System of Texas
Texas
$73K +$99.6K +10,073 New
Belvedere Trading
46
Belvedere Trading
Illinois
$52K +$13.5K +1,364 +16%
Bank of America
47
Bank of America
North Carolina
$51K +$33.5K +3,385 +97%
TRCT
48
Tower Research Capital (TRC)
New York
$33K +$45.1K +4,560 New
Citigroup
49
Citigroup
New York
$29K +$40 +4 +0.1%
PCM
50
Penserra Capital Management
California
$25K +$35.1K +3,545 New
1
2
3

HUMA Hedge Fund Activity: Q4 2021 in Review

61 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q4 2021, worth a combined $69M — down 11% from $77.5M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new HUMA positions and 9 closed out — a net gain of 30 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $13.9M. The largest seller was OrbiMed, exiting entirely with an estimated $17.4M sold.

  • 61 institutional investors held Humacyte (HUMA) as of Q4 2021, up from 32 in Q3 2021.
  • Funds reported $69M of Humacyte stock for Q4 2021, down 11% quarter-over-quarter.
  • 39 funds opened new Humacyte positions in Q4 2021 and 9 closed out, a net change of +30 holders.
  • The largest Humacyte buyer in Q4 2021 was BlackRock, an estimated $13.9M added.
  • The largest Humacyte seller in Q4 2021 was OrbiMed, an estimated $17.4M sold.

Based on aggregated 13F filings for Q4 2021.